Header Logo

Connection

Christopher Codispoti to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Christopher Codispoti has written about Antibodies, Monoclonal, Humanized.
Christopher Codispoti
Connection Strength
0.632
Antibodies, Monoclonal, Humanized
  1. Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case. Ann Allergy Asthma Immunol. 2019 09; 123(3):311-312.
    View in: PubMed
    Score: 0.632
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.